Koshidacin B

Description: Koshidacin B, a cyclic tetrapeptide, exhibits potent antiplasmodial activity, evidenced by its ability to inhibit Plasmodium falciparum strains FCR3 and K1 with IC50 values of 0.89 µM and 0.83 µM, respectively. It has been shown to effectively suppress malaria parasites in vivo and has potential applications in parasitic infection research [1]. Target: Others